Delphi Ventures is a U.S. venture capital firm focused on early stage healthcare investing, including medical devices and diagnostics, biotechnology, and healthcare services companies. Delphi-backed companies have raised more than $4 billion in capital. More than 50 of our companies have either completed an initial public offering or have been acquired by leading healthcare corporations.
Healthcare investing is what Delphi does every day. It has been our focus since the firm was founded more than a decade ago. Our job is to find and nurture teams determined to improve the way we live. Despite market cycles, we've remained committed. Limited Partners that invest in Delphi are rewarded with excellent financial returns while knowing that their contribution has supported the discovery of new ways to treat life-threatening diseases, the development of essential medical devices, and major improvements in the delivery of healthcare. We take pride in our venture capital abilities, and in the direct impact that healthcare innovation has on the quality of human life.